published meta-analysis   sensitivity analysis   studies

antiviral and associated therapy in COVID-19 (hospitalized or not) - Summary of results

OutcomeTE95% CInkI2ROBPub. bias radiologic improvement (14-day)detailed resultsHong Zhao, 2021 3.16 [0.62; 16.10] 3.16[0.62; 16.10]Hong Zhao, 202110%12NAnot evaluable serious adverse eventsdetailed resultsHong Zhao, 2021 1.44 [0.02; 87.17] 1.44[0.02; 87.17]Hong Zhao, 202110%12NAnot evaluable0.55.01.0relative treatment effectwww.metaEvidence.org2024-05-12 14:00 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 87 - treatments: 545,1253,519,619,537,514,688,529,508,656,657,832,530,512,515,754,1142,1419,513,884,632,559,889,956,684,886,631,574,509,542,1145,555,554,941,961,1250,633,676,518,532,510,528,520,955,815,893,623,622,630,593,569,516,814 - roots T: 290